Evidence map›Paper›PMID 26090364›Full record

ArticleFrontiers in cell and developmental biology2015

In vitro alteration of physiological parameters do not hamper the growth of human multipotent vascular wall-mesenchymal stem cells.

Carmen Ciavarella, Silvia Fittipaldi, Silvia Pedrini, Francesco Vasuri, Enrico Gallitto, Antonio Freyrie, Andrea Stella, Elena Gostjeva, Gianandrea Pasquinelli

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Frontiers in cell and developmental biology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 2 countries.

Carmen CiavarellaLaboratory of Clinic Pathology, Department of Specialty, Diagnostic and Experimental Medicine (DIMES), S. Orsola-Malpighi Hospital, University of Bologna Bologna, Italy.
Silvia FittipaldiLaboratory of Clinic Pathology, Department of Specialty, Diagnostic and Experimental Medicine (DIMES), S. Orsola-Malpighi Hospital, University of Bologna Bologna, Italy ; Laboratory of Metakaryotic Biology, Department of Biological Engineering, Massachusetts Institute of Technology Cambridge, MA, USA.
Silvia PedriniLaboratory of Clinic Pathology, Department of Specialty, Diagnostic and Experimental Medicine (DIMES), S. Orsola-Malpighi Hospital, University of Bologna Bologna, Italy.
Francesco VasuriUnit of Surgical Pathology, Department of Specialty, Diagnostic and Experimental Medicine (DIMES), S. Orsola-Malpighi Hospital, University of Bologna Bologna, Italy.
Enrico GallittoUnit of Vascular Surgery, Department of Specialty, Diagnostic and Experimental Medicine (DIMES), S. Orsola-Malpighi Hospital, University of Bologna Bologna, Italy.
Antonio FreyrieUnit of Vascular Surgery, Department of Specialty, Diagnostic and Experimental Medicine (DIMES), S. Orsola-Malpighi Hospital, University of Bologna Bologna, Italy.
Andrea StellaUnit of Vascular Surgery, Department of Specialty, Diagnostic and Experimental Medicine (DIMES), S. Orsola-Malpighi Hospital, University of Bologna Bologna, Italy.
Elena GostjevaLaboratory of Metakaryotic Biology, Department of Biological Engineering, Massachusetts Institute of Technology Cambridge, MA, USA.
Gianandrea PasquinelliUnit of Surgical Pathology, Department of Specialty, Diagnostic and Experimental Medicine (DIMES), S. Orsola-Malpighi Hospital, University of Bologna Bologna, Italy.
University of Bologna · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMesenchymal stem cells (MSCs) with multilineage potential and anti-inflammatory property can be isolated from different human tissues, representing promising candidates in regenerative medicine. Despite the common criteria of characterization, many factors contribute to MSC heterogeneity (i.e., tissue origin, coexistence of cell subsets at different stage of differentiation, epigenetic) and no standard methods have been approved to characterize MSCs in cell culture.

aimThe present study aimed to test whether MSCs resist adverse chemical and physical culture conditions, surviving MSC subpopulations are endowed with the stemness abilities; to characterize MMP expression in AAA-MSCs under the adverse experimental conditions. METHODS AND

resultsMSCs enzymatically isolated from human abdominal aortic aneurysm (AAA-MSCs) were exposed to media acidification, hypoxia, starving, drying and hypothermia through the following strategies: (1) low-density seeding in closed flasks; (2) exposure to a chemical hypoxia inducer, cobalt chloride; (3) exposure to a dry environment with growing medium deprivation and culture at 4°C. None of these conditions affected MSC viability and stemness profile, as evidenced by NANOG, OCT-4, and SOX-2 mRNA expression in surviving cells. A significant MMP-9 decrease, especially when AAA-MSCs were exposed to hypothermia, was associated with stress resistant stem cells.

conclusionsAAA-MSCs survive to extremely adverse culture conditions, keeping their morphology and stemness features. Besides MMP-9 role in pathological tissue remodeling, this protease may be related to MSC survival. Future studies on MSCs derived from other tissues will be necessary to refine our culture protocol, which can represent an empirical method to demonstrate MSC stemness, with potential implications for their clinical use.

Indexed as

anhydrobiosisdry culturehypothermiahypoxiaMMP-9MSCssurvival

Identifiers

PMID26090364
PMCPMC4455290
OpenAlexW2002701980

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.